Related references
Note: Only part of the references are listed.Leishmaniasis chemotherapy-challenges and opportunities
S. L. Croft et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: Synthesis and in vitro biological evaluation
Fatemeh Poorrajab et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species
Fatemeh Poorrajab et al.
EXPERIMENTAL PARASITOLOGY (2009)
First-Line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony
Cesar Miranda-Verastegui et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines
Mina Behrouzi-Fardmoghadam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Pretreatment of macrophages with the combination of IFN-γ and IL-12 induces resistance to Leishmania major at the early phase of infection
Haruko Ota et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2008)
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist
Peter E. Kima
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2007)
Interleukin-10 and the pathogenesis of human visceral leishmaniasis
Susanne Nylen et al.
TRENDS IN IMMUNOLOGY (2007)
Targeting atypical trypanosomatid DNA topoisomerase I
Rafael Balana-Fouce et al.
DRUG DISCOVERY TODAY (2006)
Antitrypanosomal and antileishmanial activities of flavonoids and their analogues:: In vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies
D Tasdemir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Protein kinases as drug targets in trypanosomes and Leishmania
C Naula et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection
WKV Pereira et al.
JOURNAL OF INFECTION (2005)
T helper (h)1/Th2 and Leishmania:: paradox rather than paradigm
J Alexander et al.
IMMUNOLOGY LETTERS (2005)
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
F Pasquau et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis
A Dutta et al.
PARASITOLOGY INTERNATIONAL (2005)
Immunopathogenesis of infection with the visceralizing Leishmania species
ME Wilson et al.
MICROBIAL PATHOGENESIS (2005)
Subversion mechanisms by which Leishmania parasites can escape the host immune response:: a signaling point of view
M Olivier et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
The murine model of infection with Leishmania major and its importance for the deciphering of mechanisms underlying differences in Th cell differentiation in mice from different genetic backgrounds
A Gumy et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2004)
Leishmaniasis - current chemotherapy and recent advances in the search for novel drugs
SL Croft et al.
TRENDS IN PARASITOLOGY (2003)
Intracellular parasitism: cell biological adaptations of parasitic protozoa to a life inside cells
J Nyalwidhe et al.
ZOOLOGY (2003)
In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5′-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice
FM Uckun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Cell biology of Leishmania spp.: Invading and evading
MA Vannier-Santos et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Chemotherapy of leishmaniasis
SL Croft et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii
V Yardley et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator
I Arevalo et al.
CLINICAL INFECTIOUS DISEASES (2001)
Immunopharmacology of antibiotics: Direct and indirect immunomodulation of defence mechanisms
JMT Hamilton-Miller
JOURNAL OF CHEMOTHERAPY (2001)
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response
L Das et al.
JOURNAL OF IMMUNOLOGY (2001)
Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB/c mice
T Ghazanfari et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2000)
Interference of antibacterial agents with phagocyte functions: Immunomodulation or immuno-fairy tales?
MT Labro
CLINICAL MICROBIOLOGY REVIEWS (2000)
Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells
E Reyes et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
